1. Home
  2. OBIO vs PEW Comparison

OBIO vs PEW Comparison

Compare OBIO & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • PEW
  • Stock Information
  • Founded
  • OBIO 2017
  • PEW 2007
  • Country
  • OBIO United States
  • PEW United States
  • Employees
  • OBIO N/A
  • PEW N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • PEW Other Specialty Stores
  • Sector
  • OBIO Health Care
  • PEW Consumer Discretionary
  • Exchange
  • OBIO Nasdaq
  • PEW Nasdaq
  • Market Cap
  • OBIO 146.2M
  • PEW 156.5M
  • IPO Year
  • OBIO N/A
  • PEW N/A
  • Fundamental
  • Price
  • OBIO $2.74
  • PEW $5.10
  • Analyst Decision
  • OBIO Strong Buy
  • PEW Strong Buy
  • Analyst Count
  • OBIO 4
  • PEW 1
  • Target Price
  • OBIO $14.00
  • PEW $8.25
  • AVG Volume (30 Days)
  • OBIO 227.6K
  • PEW 1.2M
  • Earning Date
  • OBIO 11-11-2025
  • PEW 11-14-2025
  • Dividend Yield
  • OBIO N/A
  • PEW N/A
  • EPS Growth
  • OBIO N/A
  • PEW N/A
  • EPS
  • OBIO N/A
  • PEW N/A
  • Revenue
  • OBIO $2,944,000.00
  • PEW $90,690,000.00
  • Revenue This Year
  • OBIO $29.26
  • PEW N/A
  • Revenue Next Year
  • OBIO $10.65
  • PEW N/A
  • P/E Ratio
  • OBIO N/A
  • PEW $45.90
  • Revenue Growth
  • OBIO 41.61
  • PEW N/A
  • 52 Week Low
  • OBIO $2.20
  • PEW $4.34
  • 52 Week High
  • OBIO $6.50
  • PEW $21.40
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 59.98
  • PEW 42.73
  • Support Level
  • OBIO $2.20
  • PEW $4.34
  • Resistance Level
  • OBIO $2.89
  • PEW $5.82
  • Average True Range (ATR)
  • OBIO 0.14
  • PEW 0.33
  • MACD
  • OBIO 0.04
  • PEW 0.02
  • Stochastic Oscillator
  • OBIO 78.26
  • PEW 50.68

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About PEW GrabAGun Digital Holdings Inc. Common Stock

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition, and related accessories.

Share on Social Networks: